Evidence map›Paper›PMID 34068706›Full record

ReviewMolecules (Basel, Switzerland)2021

Recent Trends in Enzyme Immobilization-Concepts for Expanding the Biocatalysis Toolbox.

Hans-Jürgen Federsel, Thomas S Moody, Steve J C Taylor

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Research in the Field of Drug Design and Development.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  16. Transglutaminase in Foods and Biotechnology.International journal of molecular sciences · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hans-Jürgen FederselRISE Research Institutes of Sweden, Department of Chemical Process and Pharmaceutical Development, P.O. Box 5607, S-114 86 Stockholm, Sweden.ORCID 0000-0001-5781-1689
Thomas S MoodyAlmac Sciences Ltd., 20 Seagoe Industrial Estate, Craigavon BT63 5QD, UK.ORCID 0000-0002-8266-0269
Steve J C TaylorAlmac Sciences Ltd., 20 Seagoe Industrial Estate, Craigavon BT63 5QD, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enzymes have been exploited by humans for thousands of years in brewing and baking, but it is only recently that biocatalysis has become a mainstream technology for synthesis. Today, enzymes are used extensively in the manufacturing of pharmaceuticals, food, fine chemicals, flavors, fragrances and other products. Enzyme immobilization technology has also developed in parallel as a means of increasing enzyme performance and reducing process costs. The aim of this review is to present and discuss some of the more recent promising technical developments in enzyme immobilization, including the supports used, methods of fabrication, and their application in synthesis. The review highlights new support technologies such as the use of well-established polysaccharides in novel ways, the use of magnetic particles, DNA, renewable materials and hybrid organic-inorganic supports. The review also addresses how immobilization is being integrated into developing biocatalytic technology, for example in flow biocatalysis, the use of 3D printing and multi-enzymatic cascade reactions.

Indexed as

BiocatalysisEnzymes, ImmobilizedMagnetite NanoparticlesMetal-Organic FrameworksPrinting, Three-DimensionalProtein EngineeringEnzymes, ImmobilizedMagnetite NanoparticlesMetal-Organic Frameworks3D-printingbiocatalysisenzymeflow processesimmobilizationsupport technologies

Identifiers

PMID34068706
PMCPMC8126217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.